data_1dl0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dl0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.41 HG13 ' CZ ' ' A' ' 31' ' ' TYR . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.411 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.7 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.2 tptm . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.42 HG12 ' CZ ' ' A' ' 31' ' ' TYR . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 tttt . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.407 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CD ' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 31' ' ' TYR . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 pttt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.44 147.98 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.618 -0.676 . . . . 0.0 109.415 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.41 HG13 ' CZ ' ' A' ' 31' ' ' TYR . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.38 148.28 15.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -57.35 160.01 4.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.695 -0.628 . . . . 0.0 110.097 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -118.33 164.8 18.57 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.425 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 123.46 2.774 . . . . 0.0 110.474 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt -72.85 157.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.71 . . . . 0.0 109.314 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.409 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.411 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ttpm? -55.22 105.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.67 -176.98 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.792 -0.568 . . . . 0.0 109.782 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -155.13 82.35 3.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.447 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 123.469 2.779 . . . . 0.0 110.471 -179.879 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -81.58 153.77 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.39 106.99 0.33 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.29 168.45 1.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.804 -0.56 . . . . 0.0 110.019 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.91 85.43 23.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.426 2.751 . . . . 0.0 110.47 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.05 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.592 -0.693 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.406 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 15.7 tttt -57.31 90.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -165.59 165.23 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.807 -0.558 . . . . 0.0 109.508 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 161.97 69.37 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.574 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 C-N-CA 123.462 2.775 . . . . 0.0 110.509 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt -64.53 152.02 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.577 -0.702 . . . . 0.0 109.33 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -54.63 148.82 11.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.2 160.18 5.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 109.99 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.37 161.2 31.49 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.472 2.781 . . . . 0.0 110.447 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -65.44 155.07 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.402 ' CG2' ' CB ' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -58.7 143.09 47.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.04 163.74 5.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.813 -0.554 . . . . 0.0 109.793 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -155.13 68.41 5.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.683 . . . . 0.0 109.392 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 123.487 2.791 . . . . 0.0 110.47 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -177.32 153.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.499 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -56.99 146.47 26.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -62.02 163.27 8.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.804 -0.56 . . . . 0.0 109.668 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -108.33 152.3 41.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.422 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 C-N-CA 123.276 2.651 . . . . 0.0 110.456 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt -82.76 162.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.242 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.1 ptmt -59.91 140.81 56.41 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.52 176.17 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.765 -0.584 . . . . 0.0 109.761 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.53 82.74 44.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.593 -0.692 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 123.459 2.773 . . . . 0.0 110.485 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.74 151.19 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.591 -0.693 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.3 122.68 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.95 166.85 0.91 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.637 -0.664 . . . . 0.0 110.033 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.59 158.92 42.14 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 C-N-CA 123.488 2.792 . . . . 0.0 110.482 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.06 152.32 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.645 -0.66 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.4 ' CB ' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.4 ' CG2' ' CB ' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.84 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -164.7 170.8 15.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -88.69 161.23 42.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.736 0 C-N-CA 123.465 2.777 . . . . 0.0 110.481 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.2 150.2 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.41 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.504 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -55.54 150.29 12.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.47 164.05 3.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.737 -0.602 . . . . 0.0 109.924 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -71.38 163.05 69.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.67 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 123.442 2.761 . . . . 0.0 110.495 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt -100.75 151.05 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -54.7 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -164.45 166.25 20.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -133.54 91.0 27.36 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 0.0 109.637 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 123.369 2.713 . . . . 0.0 110.542 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -71.88 160.29 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 109.336 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -55.39 148.87 14.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.67 167.69 1.42 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.75 -0.594 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.37 88.43 14.78 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.398 2.732 . . . . 0.0 110.484 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt -63.59 153.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.402 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.496 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.42 HG12 ' CZ ' ' A' ' 31' ' ' TYR . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.13 141.67 53.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.27 172.78 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.765 -0.584 . . . . 0.0 110.036 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.96 109.78 59.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.498 1.783 0 C-N-CA 123.08 2.52 . . . . 0.0 110.495 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt -63.93 151.62 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.682 . . . . 0.0 109.344 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.83 149.06 9.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.27 157.38 13.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.724 -0.61 . . . . 0.0 109.858 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -138.77 81.97 21.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.705 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 123.487 2.791 . . . . 0.0 110.481 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.14 147.25 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.36 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.53 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.41 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.91 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.89 179.31 7.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.812 -0.555 . . . . 0.0 109.676 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.4 75.6 38.73 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 C-N-CA 123.476 2.784 . . . . 0.0 110.532 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt -63.41 136.93 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.564 -0.71 . . . . 0.0 109.333 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.411 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -56.64 145.12 29.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -60.56 171.12 1.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.747 -0.596 . . . . 0.0 109.903 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -154.09 84.31 4.08 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.656 -0.653 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.428 2.752 . . . . 0.0 110.488 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt -74.95 138.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.702 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.513 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -55.89 147.01 20.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.19 -177.08 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.197 0.522 . . . . 0.0 109.832 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -145.0 162.48 37.75 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 123.441 2.761 . . . . 0.0 110.503 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt -91.63 153.96 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.606 -0.683 . . . . 0.0 109.588 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.404 ' CD ' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 12.2 tttt -55.55 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -164.37 166.07 21.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 159.78 42.04 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.535 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.496 1.672 0 C-N-CA 123.435 2.756 . . . . 0.0 110.53 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -72.74 149.09 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.407 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CD ' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 HG11 ' CE1' ' A' ' 31' ' ' TYR . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -56.58 145.79 27.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.89 -172.96 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -131.76 153.22 81.4 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.755 0 C-N-CA 123.29 2.66 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 8' ' ' ARG . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.923 HG21 ' HB2' ' A' ' 6' ' ' ALA . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.976 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' CG ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.976 HG21 ' HB2' ' A' ' 6' ' ' ALA . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HA ' HG22 ' A' ' 20' ' ' THR . 1.5 ttpm? . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 8' ' ' ARG . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.892 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.82 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' OH ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' OH ' HG11 ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' H ' ' HB1' ' A' ' 6' ' ' ALA . 15.7 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 8' ' ' ARG . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.891 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 8' ' ' ARG . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.924 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 20' ' ' THR . 4.9 ptmt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 8' ' ' ARG . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.911 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.911 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 20' ' ' THR . 1.2 ttpp . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' ARG . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.912 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.912 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 20' ' ' THR . 5.1 ptmt . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 8' ' ' ARG . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.79 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.926 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.926 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.982 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.982 HG21 ' HB2' ' A' ' 6' ' ' ALA . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' CD ' HG22 ' A' ' 20' ' ' THR . 1.2 mmmp? . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 8' ' ' ARG . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HD2' HG22 ' A' ' 20' ' ' THR . 22.2 tptm . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.91 HG21 ' HB2' ' A' ' 6' ' ' ALA . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG11 ' OH ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' HG11 ' A' ' 29' ' ' VAL . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.907 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.907 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 8' ' ' ARG . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.883 HG21 ' HB2' ' A' ' 6' ' ' ALA . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 8' ' ' ARG . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.887 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.887 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 8' ' ' ARG . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.931 HG21 ' HB2' ' A' ' 6' ' ' ALA . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.906 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.56 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.906 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 20' ' ' THR . 3.0 ttpt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.902 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.902 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 20' ' ' THR . 12.2 tttt . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 8' ' ' ARG . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.916 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.916 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 20' ' ' THR . 21.0 pttt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.44 147.98 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.618 -0.676 . . . . 0.0 109.415 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 8' ' ' ARG . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.923 HG21 ' HB2' ' A' ' 6' ' ' ALA . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -55.38 148.28 15.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -57.35 160.01 4.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.695 -0.628 . . . . 0.0 110.097 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -118.33 164.8 18.57 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.425 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 123.46 2.774 . . . . 0.0 110.474 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt -72.85 157.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.71 . . . . 0.0 109.314 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.976 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' CG ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.976 HG21 ' HB2' ' A' ' 6' ' ' ALA . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HA ' HG22 ' A' ' 20' ' ' THR . 1.5 ttpm? -55.22 105.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.67 -176.98 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.792 -0.568 . . . . 0.0 109.782 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -155.13 82.35 3.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.447 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 123.469 2.779 . . . . 0.0 110.471 -179.879 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -81.58 153.77 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 8' ' ' ARG . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.892 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -56.39 106.99 0.33 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.29 168.45 1.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.804 -0.56 . . . . 0.0 110.019 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.91 85.43 23.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.426 2.751 . . . . 0.0 110.47 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.05 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.592 -0.693 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.82 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' OH ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' OH ' HG11 ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' H ' ' HB1' ' A' ' 6' ' ' ALA . 15.7 tttt -57.31 90.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -165.59 165.23 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.807 -0.558 . . . . 0.0 109.508 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 161.97 69.37 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.574 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 C-N-CA 123.462 2.775 . . . . 0.0 110.509 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt -64.53 152.02 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.577 -0.702 . . . . 0.0 109.33 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 8' ' ' ARG . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.891 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -54.63 148.82 11.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.2 160.18 5.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 109.99 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.37 161.2 31.49 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.472 2.781 . . . . 0.0 110.447 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -65.44 155.07 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 8' ' ' ARG . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.924 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 20' ' ' THR . 4.9 ptmt -58.7 143.09 47.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.04 163.74 5.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.813 -0.554 . . . . 0.0 109.793 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -155.13 68.41 5.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.683 . . . . 0.0 109.392 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 123.487 2.791 . . . . 0.0 110.47 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -177.32 153.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 8' ' ' ARG . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.911 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.911 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 20' ' ' THR . 1.2 ttpp -56.99 146.47 26.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -62.02 163.27 8.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.804 -0.56 . . . . 0.0 109.668 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -108.33 152.3 41.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.422 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 C-N-CA 123.276 2.651 . . . . 0.0 110.456 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt -82.76 162.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.242 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' ARG . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.912 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.912 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 20' ' ' THR . 5.1 ptmt -59.91 140.81 56.41 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.52 176.17 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.765 -0.584 . . . . 0.0 109.761 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.53 82.74 44.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.593 -0.692 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 123.459 2.773 . . . . 0.0 110.485 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.74 151.19 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.591 -0.693 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 8' ' ' ARG . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.79 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.3 122.68 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.95 166.85 0.91 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.637 -0.664 . . . . 0.0 110.033 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.59 158.92 42.14 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 C-N-CA 123.488 2.792 . . . . 0.0 110.482 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.06 152.32 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.645 -0.66 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.926 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.926 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -54.84 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -164.7 170.8 15.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -88.69 161.23 42.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.736 0 C-N-CA 123.465 2.777 . . . . 0.0 110.481 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.2 150.2 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.982 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.982 HG21 ' HB2' ' A' ' 6' ' ' ALA . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' CD ' HG22 ' A' ' 20' ' ' THR . 1.2 mmmp? -55.54 150.29 12.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.47 164.05 3.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.737 -0.602 . . . . 0.0 109.924 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -71.38 163.05 69.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.67 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 123.442 2.761 . . . . 0.0 110.495 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt -100.75 151.05 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 8' ' ' ARG . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HD2' HG22 ' A' ' 20' ' ' THR . 22.2 tptm -54.7 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -164.45 166.25 20.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -133.54 91.0 27.36 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 0.0 109.637 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 123.369 2.713 . . . . 0.0 110.542 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -71.88 160.29 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 109.336 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.91 HG21 ' HB2' ' A' ' 6' ' ' ALA . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG11 ' OH ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' HG11 ' A' ' 29' ' ' VAL . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -55.39 148.87 14.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.67 167.69 1.42 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.75 -0.594 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.37 88.43 14.78 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.398 2.732 . . . . 0.0 110.484 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt -63.59 153.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.907 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.907 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.13 141.67 53.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.27 172.78 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.765 -0.584 . . . . 0.0 110.036 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.96 109.78 59.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.498 1.783 0 C-N-CA 123.08 2.52 . . . . 0.0 110.495 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt -63.93 151.62 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.682 . . . . 0.0 109.344 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 8' ' ' ARG . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.883 HG21 ' HB2' ' A' ' 6' ' ' ALA . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.83 149.06 9.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.27 157.38 13.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.724 -0.61 . . . . 0.0 109.858 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -138.77 81.97 21.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.705 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 123.487 2.791 . . . . 0.0 110.481 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.14 147.25 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.36 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 8' ' ' ARG . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.887 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.887 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -54.91 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.89 179.31 7.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.812 -0.555 . . . . 0.0 109.676 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.4 75.6 38.73 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 C-N-CA 123.476 2.784 . . . . 0.0 110.532 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt -63.41 136.93 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.564 -0.71 . . . . 0.0 109.333 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 8' ' ' ARG . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.931 HG21 ' HB2' ' A' ' 6' ' ' ALA . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -56.64 145.12 29.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -60.56 171.12 1.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.747 -0.596 . . . . 0.0 109.903 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -154.09 84.31 4.08 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.656 -0.653 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.428 2.752 . . . . 0.0 110.488 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt -74.95 138.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.702 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.906 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.56 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.906 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 20' ' ' THR . 3.0 ttpt -55.89 147.01 20.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.19 -177.08 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.197 0.522 . . . . 0.0 109.832 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -145.0 162.48 37.75 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 123.441 2.761 . . . . 0.0 110.503 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt -91.63 153.96 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.606 -0.683 . . . . 0.0 109.588 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.902 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.902 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 20' ' ' THR . 12.2 tttt -55.55 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -164.37 166.07 21.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 159.78 42.04 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.535 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.496 1.672 0 C-N-CA 123.435 2.756 . . . . 0.0 110.53 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -72.74 149.09 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 8' ' ' ARG . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.916 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.916 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 20' ' ' THR . 21.0 pttt -56.58 145.79 27.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.89 -172.96 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -131.76 153.22 81.4 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.755 0 C-N-CA 123.29 2.66 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 8' ' ' ARG . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.923 HG21 ' HB2' ' A' ' 6' ' ' ALA . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.976 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' CG ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.976 HG21 ' HB2' ' A' ' 6' ' ' ALA . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.421 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HA ' HG22 ' A' ' 20' ' ' THR . 1.5 ttpm? . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.492 1.672 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 8' ' ' ARG . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.892 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.82 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' OH ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.447 ' OH ' HG11 ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' H ' ' HB1' ' A' ' 6' ' ' ALA . 15.7 tttt . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 8' ' ' ARG . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.891 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 8' ' ' ARG . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.924 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 20' ' ' THR . 4.9 ptmt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 8' ' ' ARG . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.911 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.911 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 20' ' ' THR . 1.2 ttpp . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' ARG . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.912 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.912 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 20' ' ' THR . 5.1 ptmt . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 8' ' ' ARG . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.79 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.926 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.926 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.982 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.982 HG21 ' HB2' ' A' ' 6' ' ' ALA . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' CD ' HG22 ' A' ' 20' ' ' THR . 1.2 mmmp? . . . . . 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 8' ' ' ARG . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HD2' HG22 ' A' ' 20' ' ' THR . 22.2 tptm . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 N--CA 1.492 1.671 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.91 HG21 ' HB2' ' A' ' 6' ' ' ALA . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG11 ' OH ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' HG11 ' A' ' 29' ' ' VAL . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.907 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.907 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 8' ' ' ARG . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.883 HG21 ' HB2' ' A' ' 6' ' ' ALA . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 8' ' ' ARG . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.887 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.887 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt . . . . . 0 N--CA 1.493 1.698 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 8' ' ' ARG . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.931 HG21 ' HB2' ' A' ' 6' ' ' ALA . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.906 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.56 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.906 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 20' ' ' THR . 3.0 ttpt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.902 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.467 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.902 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 20' ' ' THR . 12.2 tttt . . . . . 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 8' ' ' ARG . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.916 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.916 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.42 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 20' ' ' THR . 21.0 pttt . . . . . 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.44 147.98 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.618 -0.676 . . . . 0.0 109.415 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.0 p -122.49 175.68 6.32 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.685 -0.634 . . . . 0.0 109.653 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 8' ' ' ARG . 99.0 m -81.27 -73.42 0.38 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.71 141.8 4.5 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.923 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.38 164.79 0.29 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.618 -0.931 . . . . 0.0 110.443 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 50.71 24.8 1.83 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.766 -0.584 . . . . 0.0 111.224 179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.461 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.83 159.14 72.66 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.416 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.21 124.93 8.17 Favored 'Trans proline' 0 N--CA 1.502 1.984 0 C-N-CA 122.982 2.455 . . . . 0.0 111.028 -179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -53.39 170.45 0.1 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.464 -0.772 . . . . 0.0 109.987 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.16 158.83 38.63 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.739 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.49 -65.94 0.47 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.459 -0.776 . . . . 0.0 110.421 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 14.9 p -50.94 -46.65 61.01 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.475 -0.766 . . . . 0.0 110.491 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -121.98 136.61 26.4 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.181 -0.949 . . . . 0.0 109.371 -132.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.01 170.1 9.91 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.803 2.335 . . . . 0.0 109.961 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.2 m -72.37 161.01 31.41 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 83.6 m -56.6 166.69 1.2 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.544 -0.723 . . . . 0.0 109.737 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.99 108.8 2.2 Favored 'Trans proline' 0 N--CA 1.503 2.087 0 C-N-CA 122.631 2.221 . . . . 0.0 109.579 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 128.42 -37.33 2.28 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 107.606 -2.198 . . . . 0.0 107.606 -178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.923 HG21 ' HB2' ' A' ' 6' ' ' ALA . 58.9 p -98.48 155.08 17.43 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.03 148.41 52.5 Favored 'General case' 0 N--CA 1.5 2.056 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.561 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.2 t -81.33 132.58 35.34 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.502 -0.748 . . . . 0.0 109.2 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.409 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.39 123.59 15.61 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -74.44 163.36 27.87 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.519 -0.738 . . . . 0.0 109.49 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -127.04 -179.78 5.02 Favored 'General case' 0 C--N 1.31 -1.122 0 O-C-N 121.646 -0.659 . . . . 0.0 109.267 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.32 -32.19 68.31 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.764 -0.585 . . . . 0.0 109.436 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -58.0 -19.47 31.27 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.682 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.56 -18.99 40.23 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.282 -1.127 . . . . 0.0 110.282 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 24.7 t -99.34 148.14 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.302 -1.117 . . . . 0.0 109.494 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.5 m -112.36 143.66 43.1 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.762 -0.586 . . . . 0.0 109.956 -179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.8 m-85 -136.35 157.11 47.58 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.4 m -82.97 155.24 24.11 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.45 127.69 10.55 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.158 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -55.38 148.28 15.43 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.434 -0.791 . . . . 0.0 110.24 -178.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -57.35 160.01 4.31 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.695 -0.628 . . . . 0.0 110.097 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -118.33 164.8 18.57 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.65 -0.656 . . . . 0.0 109.425 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.705 0 C-N-CA 123.46 2.774 . . . . 0.0 110.474 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 15.2 tt -72.85 157.65 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.564 -0.71 . . . . 0.0 109.314 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.4 p -117.36 176.68 5.04 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.557 -0.714 . . . . 0.0 109.645 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.9 m -79.92 -73.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.679 . . . . 0.0 109.323 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 136.88 139.48 3.93 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.976 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.81 162.79 0.55 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.598 -0.942 . . . . 0.0 110.444 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 51.91 24.42 2.55 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.783 -0.573 . . . . 0.0 111.089 179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' CG ' ' HD2' ' A' ' 9' ' ' PRO . 0.0 OUTLIER -130.05 159.83 68.25 Favored Pre-proline 0 N--CA 1.494 1.765 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.7 Cg_endo -75.75 126.57 9.57 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.956 2.437 . . . . 0.0 111.111 -179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 67.6 m -53.48 169.1 0.14 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.505 -0.747 . . . . 0.0 109.908 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.44 155.99 46.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.468 -0.77 . . . . 0.0 109.851 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.14 -65.13 0.61 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.521 -0.737 . . . . 0.0 110.499 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.2 p -50.84 -44.03 59.33 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.449 -0.782 . . . . 0.0 110.602 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.8 m -125.03 133.31 24.71 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.251 -0.906 . . . . 0.0 109.198 -135.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.62 170.3 10.33 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.798 2.332 . . . . 0.0 110.172 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 37.4 m -70.83 159.31 34.83 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 71.9 m -56.77 165.89 1.54 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.572 -0.705 . . . . 0.0 109.794 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.3 Cg_endo -70.21 101.64 1.0 Allowed 'Trans proline' 0 N--CA 1.502 2.018 0 C-N-CA 122.72 2.28 . . . . 0.0 109.771 179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.16 -38.47 1.73 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 107.529 -2.228 . . . . 0.0 107.529 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.976 HG21 ' HB2' ' A' ' 6' ' ' ALA . 59.9 p -99.16 156.02 17.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -132.79 152.03 51.88 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.366 -0.834 . . . . 0.0 110.431 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 t -81.99 131.08 35.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.421 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.49 127.53 19.52 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.761 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.88 163.32 26.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.456 -0.777 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -128.64 178.63 6.19 Favored 'General case' 0 C--N 1.31 -1.117 0 O-C-N 121.529 -0.732 . . . . 0.0 109.328 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -32.39 67.79 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -58.23 -19.42 33.78 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.517 -0.739 . . . . 0.0 110.603 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.39 -19.71 36.37 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 29.2 t -99.49 150.54 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.312 -1.11 . . . . 0.0 109.489 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 51.0 m -107.91 141.13 40.0 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 120.136 -0.626 . . . . 0.0 109.846 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 59.7 m-85 -136.36 156.65 48.33 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 82.3 m -83.71 155.62 23.01 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.421 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.2 125.9 9.63 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.078 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.732 ' HA ' HG22 ' A' ' 20' ' ' THR . 1.5 ttpm? -55.22 105.19 0.15 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.506 -0.746 . . . . 0.0 110.438 -178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.67 -176.98 0.06 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.792 -0.568 . . . . 0.0 109.782 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -155.13 82.35 3.97 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.604 -0.685 . . . . 0.0 109.447 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.64 0 C-N-CA 123.469 2.779 . . . . 0.0 110.471 -179.879 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.3 tt -81.58 153.77 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.599 -0.688 . . . . 0.0 109.332 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 14.8 p -119.09 174.27 6.42 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.582 -0.699 . . . . 0.0 109.569 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.533 HG22 ' HB3' ' A' ' 8' ' ' ARG . 90.4 m -79.83 -72.16 0.42 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.598 -0.688 . . . . 0.0 109.422 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.59 142.36 4.98 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.892 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.45 165.57 0.24 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.572 -0.958 . . . . 0.0 110.333 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 49.89 25.48 1.62 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.805 -0.559 . . . . 0.0 111.135 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.533 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -131.56 159.0 73.77 Favored Pre-proline 0 N--CA 1.496 1.852 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.749 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.1 Cg_endo -75.76 128.73 11.11 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.912 2.408 . . . . 0.0 111.074 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 92.3 m -56.12 173.21 0.17 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.503 -0.748 . . . . 0.0 109.746 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.61 156.54 48.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.96 -45.07 60.71 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.485 -0.759 . . . . 0.0 110.517 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.9 m -124.08 133.44 24.67 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.28 -134.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.82 170.19 10.12 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.866 2.377 . . . . 0.0 110.02 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.76 158.85 35.59 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 92.7 m -56.71 166.41 1.33 Allowed Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.546 -0.722 . . . . 0.0 109.742 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.2 Cg_endo -70.29 108.64 2.23 Favored 'Trans proline' 0 N--CA 1.502 2.011 0 C-N-CA 122.693 2.262 . . . . 0.0 109.551 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.18 -38.15 2.07 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.892 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 62.1 p -98.95 157.75 16.11 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.16 154.93 49.04 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.197 -0.939 . . . . 0.0 110.751 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 24.2 t -86.93 133.69 33.58 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.47 -0.769 . . . . 0.0 109.363 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.41 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.23 177.44 8.08 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -115.63 161.01 19.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.48 -0.763 . . . . 0.0 109.416 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -124.36 177.16 6.02 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.561 -0.712 . . . . 0.0 109.185 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.56 -33.55 69.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -57.94 -19.75 32.49 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.528 -0.732 . . . . 0.0 110.576 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -15.67 43.9 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.9 t -99.57 148.47 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -1.169 . . . . 0.0 109.637 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -102.27 145.1 29.93 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 121.34 0.59 . . . . 0.0 109.936 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 79.7 m-85 -139.97 158.82 43.46 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 84.7 m -86.61 157.0 19.8 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.41 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.9 126.11 9.95 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -56.39 106.99 0.33 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.517 -0.739 . . . . 0.0 110.163 -178.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -58.29 168.45 1.07 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.804 -0.56 . . . . 0.0 110.019 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -136.91 85.43 23.27 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.629 -0.669 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.426 2.751 . . . . 0.0 110.47 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.7 tp -62.05 153.43 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.592 -0.693 . . . . 0.0 109.358 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.7 p -116.85 170.74 8.38 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.594 -0.691 . . . . 0.0 109.614 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 89.2 m -80.47 -71.92 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.02 138.78 4.03 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.82 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.72 165.79 0.25 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.599 -0.942 . . . . 0.0 110.14 179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 52.42 23.91 2.71 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.767 -0.583 . . . . 0.0 110.856 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.0 160.24 69.32 Favored Pre-proline 0 N--CA 1.495 1.819 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -75.94 123.6 7.46 Favored 'Trans proline' 0 N--CA 1.5 1.9 0 C-N-CA 122.861 2.374 . . . . 0.0 110.945 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.7 m -53.34 172.86 0.05 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.523 -0.736 . . . . 0.0 109.91 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.88 158.76 38.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.584 -0.697 . . . . 0.0 109.636 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.64 -65.73 0.51 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.474 -0.766 . . . . 0.0 110.369 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.8 p -51.04 -46.46 61.64 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.441 -0.787 . . . . 0.0 110.475 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.8 m -121.85 138.98 29.38 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.172 -0.955 . . . . 0.0 109.452 -132.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -85.41 170.02 9.42 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.822 2.348 . . . . 0.0 109.879 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.2 m -74.72 160.29 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 78.5 m -57.02 166.9 1.24 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.566 -0.709 . . . . 0.0 109.654 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -68.92 130.79 21.04 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 122.58 2.187 . . . . 0.0 109.304 179.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 103.48 -33.48 6.54 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 107.771 -2.131 . . . . 0.0 107.771 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.82 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 26.5 p -98.78 165.71 11.65 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.28 141.26 28.43 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.165 -0.96 . . . . 0.0 110.936 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.6 t -68.72 144.66 54.33 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.486 -0.759 . . . . 0.0 108.989 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 14.0 mttm -140.67 173.12 11.81 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -124.78 153.03 43.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.446 -0.783 . . . . 0.0 109.475 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -121.39 173.22 7.5 Favored 'General case' 0 C--N 1.31 -1.149 0 O-C-N 121.552 -0.717 . . . . 0.0 109.319 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.45 -35.6 70.96 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -58.93 -18.41 33.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.638 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.95 -8.72 46.22 Favored Glycine 0 N--CA 1.495 2.582 0 C-N-CA 120.213 -0.994 . . . . 0.0 110.651 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG11 ' OH ' ' A' ' 31' ' ' TYR . 13.0 t -99.41 143.44 13.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.146 -1.208 . . . . 0.0 109.181 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.5 m -105.68 145.64 30.79 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 120.281 -0.568 . . . . 0.0 109.957 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.447 ' OH ' HG11 ' A' ' 29' ' ' VAL . 58.3 m-85 -140.88 149.67 42.24 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.2 m -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.77 116.49 5.5 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' H ' ' HB1' ' A' ' 6' ' ' ALA . 15.7 tttt -57.31 90.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.697 -0.627 . . . . 0.0 110.659 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -165.59 165.23 19.01 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.807 -0.558 . . . . 0.0 109.508 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.86 161.97 69.37 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.565 -0.71 . . . . 0.0 109.574 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.496 1.63 0 C-N-CA 123.462 2.775 . . . . 0.0 110.509 179.963 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.0 tt -64.53 152.02 8.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.577 -0.702 . . . . 0.0 109.33 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.7 p -118.81 173.06 7.1 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.625 -0.672 . . . . 0.0 109.6 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.527 HG22 ' HB3' ' A' ' 8' ' ' ARG . 88.6 m -80.61 -72.22 0.43 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.623 -0.673 . . . . 0.0 109.415 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.49 143.44 5.22 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.891 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.03 166.39 0.16 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.607 -0.937 . . . . 0.0 110.407 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 49.8 24.97 1.39 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.82 -0.55 . . . . 0.0 111.282 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.33 158.47 75.17 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.304 -0.873 . . . . 0.0 108.737 179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.28 124.74 8.0 Favored 'Trans proline' 0 N--CA 1.501 1.954 0 C-N-CA 122.967 2.445 . . . . 0.0 111.069 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.1 m -53.36 172.26 0.06 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.469 -0.769 . . . . 0.0 109.873 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.34 158.57 44.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.479 -0.763 . . . . 0.0 109.836 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.77 -65.81 0.49 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.565 -0.709 . . . . 0.0 110.446 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.82 -45.01 59.3 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.47 -0.769 . . . . 0.0 110.616 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.21 133.93 25.08 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 -134.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -85.2 170.2 9.62 Favored 'Trans proline' 0 N--CA 1.493 1.457 0 C-N-CA 122.815 2.343 . . . . 0.0 110.003 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -71.06 158.47 36.42 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.8 m -56.62 167.31 1.03 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.512 -0.742 . . . . 0.0 109.568 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.36 117.73 5.24 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.599 2.199 . . . . 0.0 109.494 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.59 -36.64 3.51 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -177.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.891 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 72.0 p -98.65 154.44 17.95 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.31 153.2 48.9 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.432 -0.793 . . . . 0.0 110.682 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -87.94 130.89 34.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.404 -0.81 . . . . 0.0 108.992 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.62 125.67 17.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.91 -0.494 . . . . 0.0 109.805 -179.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.01 163.94 26.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.469 -0.769 . . . . 0.0 109.239 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -129.17 -177.93 4.44 Favored 'General case' 0 N--CA 1.482 1.154 0 O-C-N 121.576 -0.703 . . . . 0.0 109.547 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.83 -32.22 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.3 p30 -58.41 -19.08 33.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.546 -0.721 . . . . 0.0 110.6 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.25 -20.87 36.76 Favored Glycine 0 N--CA 1.494 2.544 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 t -99.36 150.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.322 -1.105 . . . . 0.0 109.415 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.0 m -110.33 144.28 39.31 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 120.135 -0.626 . . . . 0.0 109.933 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 70.9 m-85 -136.08 158.77 43.62 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 179.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 70.8 m -84.29 154.32 23.02 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.96 131.54 13.07 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 22.0 mttt -54.63 148.82 11.82 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.308 -0.87 . . . . 0.0 110.219 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.2 160.18 5.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.72 -0.613 . . . . 0.0 109.99 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -93.37 161.2 31.49 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.574 -0.704 . . . . 0.0 109.493 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.497 1.691 0 C-N-CA 123.472 2.781 . . . . 0.0 110.447 -179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.5 tp -65.44 155.07 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.575 -0.703 . . . . 0.0 109.288 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 22.5 p -111.36 171.83 7.24 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.503 -0.748 . . . . 0.0 109.681 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 8' ' ' ARG . 80.4 m -81.04 -72.49 0.42 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.574 -0.704 . . . . 0.0 109.498 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.38 143.44 5.1 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.924 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.6 164.08 0.38 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.536 -0.979 . . . . 0.0 110.328 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 54.5 22.44 3.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.778 -0.576 . . . . 0.0 111.084 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.549 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.1 160.06 67.25 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.264 -0.897 . . . . 0.0 108.803 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.7 Cg_endo -76.58 126.31 8.87 Favored 'Trans proline' 0 N--CA 1.502 2.023 0 C-N-CA 123.005 2.47 . . . . 0.0 111.202 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.7 m -57.35 173.82 0.23 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.0 109.459 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.86 159.21 42.69 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.54 -0.725 . . . . 0.0 109.987 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.04 -65.54 0.54 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.556 -0.715 . . . . 0.0 110.613 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 p -50.84 -43.61 59.19 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.45 -0.781 . . . . 0.0 110.578 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.1 m -125.85 127.9 24.68 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.944 . . . . 0.0 109.163 -136.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -85.17 170.37 9.58 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.806 2.338 . . . . 0.0 110.241 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.6 m -69.37 156.37 38.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.684 -0.635 . . . . 0.0 109.311 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.8 m -57.09 166.77 1.33 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.543 -0.723 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.8 Cg_endo -69.41 120.18 7.05 Favored 'Trans proline' 0 N--CA 1.502 1.976 0 C-N-CA 122.665 2.243 . . . . 0.0 109.492 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 116.11 -36.52 3.79 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 107.544 -2.222 . . . . 0.0 107.544 -177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.924 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 46.1 p -98.51 156.79 16.61 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.83 142.03 44.78 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.243 -0.911 . . . . 0.0 110.77 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.5 t -64.44 144.68 57.01 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 26.2 mttm -140.92 175.63 9.46 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -123.33 152.73 41.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.516 -0.74 . . . . 0.0 109.17 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.16 173.22 7.71 Favored 'General case' 0 C--N 1.31 -1.114 0 O-C-N 121.517 -0.739 . . . . 0.0 109.426 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.6 -34.62 70.03 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 p30 -58.18 -19.52 33.88 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.496 -0.752 . . . . 0.0 110.589 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.95 -11.21 44.99 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.521 -1.032 . . . . 0.0 110.521 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.445 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 21.7 t -99.4 146.4 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -1.198 . . . . 0.0 109.455 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.7 m -103.9 143.68 32.52 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.295 0.569 . . . . 0.0 110.075 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 49.7 m-85 -140.84 150.38 43.19 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.6 m -73.66 161.32 30.41 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.403 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.26 122.5 8.36 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 179.162 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.411 ' HA ' HG22 ' A' ' 20' ' ' THR . 4.9 ptmt -58.7 143.09 47.92 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.561 -0.712 . . . . 0.0 110.07 -178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -61.04 163.74 5.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.813 -0.554 . . . . 0.0 109.793 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -155.13 68.41 5.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.607 -0.683 . . . . 0.0 109.392 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo . . . . . 0 N--CA 1.496 1.655 0 C-N-CA 123.487 2.791 . . . . 0.0 110.47 -179.961 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.2 tp -177.32 153.36 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.6 p -117.37 172.59 7.21 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.539 -0.726 . . . . 0.0 109.884 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.553 HG22 ' HB3' ' A' ' 8' ' ' ARG . 96.0 m -81.46 -74.09 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.9 145.18 5.26 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.911 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.14 0.19 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.484 -1.009 . . . . 0.0 110.346 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 49.15 25.32 1.14 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.828 -0.545 . . . . 0.0 111.313 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.82 160.2 68.62 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 0.0 108.734 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.03 128.12 10.47 Favored 'Trans proline' 0 N--CA 1.502 2.01 0 C-N-CA 122.979 2.453 . . . . 0.0 111.057 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 96.3 m -56.44 173.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.487 -0.758 . . . . 0.0 109.654 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.52 157.05 47.7 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.559 -0.713 . . . . 0.0 109.839 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.94 -66.43 0.39 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.57 -0.707 . . . . 0.0 110.592 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 20.0 p -50.78 -43.54 58.58 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.465 -0.772 . . . . 0.0 110.55 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.4 m -125.61 131.89 24.16 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.185 -135.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.68 169.72 10.54 Favored 'Trans proline' 0 N--CA 1.492 1.398 0 C-N-CA 122.741 2.294 . . . . 0.0 109.921 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.72 158.34 32.55 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.524 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 95.4 m -56.58 167.1 1.07 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.557 -0.714 . . . . 0.0 109.775 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.52 113.72 3.43 Favored 'Trans proline' 0 N--CA 1.503 2.051 0 C-N-CA 122.682 2.254 . . . . 0.0 109.503 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.37 -37.93 2.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 107.46 -2.256 . . . . 0.0 107.46 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.911 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 71.1 p -98.14 156.34 16.72 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.31 160.63 31.57 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.331 -0.855 . . . . 0.0 110.584 -179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 27.1 t -96.63 133.99 40.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.521 -0.737 . . . . 0.0 109.226 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -140.97 173.21 11.7 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -114.87 160.73 19.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.392 -0.817 . . . . 0.0 109.475 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.9 178.72 5.13 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.577 -0.702 . . . . 0.0 109.311 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.03 -34.03 70.89 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.791 -0.568 . . . . 0.0 109.567 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -58.25 -19.23 32.48 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.504 -0.747 . . . . 0.0 110.682 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.63 -14.55 50.06 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 26.5 t -99.39 147.3 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.221 -1.164 . . . . 0.0 109.489 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.7 m -104.34 145.79 29.75 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.255 0.55 . . . . 0.0 109.82 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 96.0 m-85 -138.36 160.62 39.02 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -88.37 156.73 18.99 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.87 127.16 10.62 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 179.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 20' ' ' THR . 1.2 ttpp -56.99 146.47 26.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.484 -0.76 . . . . 0.0 110.092 -178.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -62.02 163.27 8.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.804 -0.56 . . . . 0.0 109.668 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.8 mp0 -108.33 152.3 41.9 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.54 -0.725 . . . . 0.0 109.422 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.498 1.746 0 C-N-CA 123.276 2.651 . . . . 0.0 110.456 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 12.5 tt -82.76 162.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.583 -0.698 . . . . 0.0 109.242 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.9 p -110.42 169.92 8.42 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.528 -0.732 . . . . 0.0 109.628 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.471 HG22 ' HB3' ' A' ' 8' ' ' ARG . 63.1 m -80.35 -69.39 0.6 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.678 -0.639 . . . . 0.0 109.444 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.33 139.59 4.68 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.912 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.64 162.64 0.55 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.608 -0.937 . . . . 0.0 110.316 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 56.05 21.68 5.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.762 -0.586 . . . . 0.0 110.874 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -131.68 160.92 65.34 Favored Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -75.58 125.44 8.94 Favored 'Trans proline' 0 N--CA 1.502 2.013 0 C-N-CA 122.897 2.398 . . . . 0.0 111.29 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.7 m -56.43 175.35 0.11 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.498 -0.751 . . . . 0.0 109.573 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.82 156.53 45.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.542 -0.723 . . . . 0.0 109.985 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.18 -64.79 0.7 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.578 -0.701 . . . . 0.0 110.54 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 22.6 p -50.79 -43.52 58.67 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.45 -0.781 . . . . 0.0 110.607 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.4 m -126.21 129.06 24.31 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 -136.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -84.81 170.08 10.19 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 C-N-CA 122.809 2.339 . . . . 0.0 110.232 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.8 m -70.38 156.62 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.622 -0.674 . . . . 0.0 109.253 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 72.1 m -56.85 166.96 1.17 Allowed Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.594 -0.691 . . . . 0.0 109.421 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.5 124.83 12.03 Favored 'Trans proline' 0 N--CA 1.503 2.06 0 C-N-CA 122.524 2.15 . . . . 0.0 109.549 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.36 -36.07 4.47 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 107.714 -2.154 . . . . 0.0 107.714 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.912 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.6 p -98.51 157.16 16.4 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.86 143.47 36.76 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.337 -0.852 . . . . 0.0 110.446 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.2 t -59.84 145.46 45.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 109.608 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 2.3 mptp? -137.17 178.67 6.91 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -130.94 152.97 49.68 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.486 -0.759 . . . . 0.0 109.248 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -125.59 173.64 8.81 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-O 121.724 0.773 . . . . 0.0 109.582 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -31.76 65.97 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 25.2 p30 -58.69 -18.67 33.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.6 -0.688 . . . . 0.0 110.531 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.2 -12.46 51.98 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 31' ' ' TYR . 36.7 t -99.19 148.75 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.254 -1.145 . . . . 0.0 109.264 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 m -106.74 143.99 34.04 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.161 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 29' ' ' VAL . 30.6 m-85 -140.93 147.34 38.66 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 62.6 m -65.9 165.19 13.51 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.3 120.66 7.35 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.4 ' HA ' HG22 ' A' ' 20' ' ' THR . 5.1 ptmt -59.91 140.81 56.41 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.946 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -62.52 176.17 0.68 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.765 -0.584 . . . . 0.0 109.761 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -134.53 82.74 44.79 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.593 -0.692 . . . . 0.0 109.366 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.496 1.66 0 C-N-CA 123.459 2.773 . . . . 0.0 110.485 -179.886 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.4 tp -63.74 151.19 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.591 -0.693 . . . . 0.0 109.28 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 21.1 p -117.42 170.64 8.56 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.629 -0.669 . . . . 0.0 109.658 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.513 HG22 ' HB3' ' A' ' 8' ' ' ARG . 85.6 m -80.56 -73.53 0.36 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 133.26 142.47 4.8 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.79 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.66 165.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.5 -1.0 . . . . 0.0 110.199 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 51.71 24.25 2.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.781 -0.575 . . . . 0.0 111.084 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.31 160.21 68.17 Favored Pre-proline 0 N--CA 1.495 1.824 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.6 Cg_endo -76.75 124.36 7.47 Favored 'Trans proline' 0 N--CA 1.501 1.969 0 C-N-CA 122.996 2.464 . . . . 0.0 111.004 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 64.2 m -53.06 167.22 0.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.439 -0.788 . . . . 0.0 109.986 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.16 158.2 37.7 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.499 -0.75 . . . . 0.0 109.554 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.43 -65.52 0.54 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.433 -0.792 . . . . 0.0 110.368 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 13.0 p -51.13 -47.52 61.99 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.45 -0.781 . . . . 0.0 110.486 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.9 m -120.92 139.79 29.74 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.173 -0.954 . . . . 0.0 109.493 -131.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -85.12 170.55 9.58 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.927 2.418 . . . . 0.0 109.942 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.0 m -74.73 159.24 32.27 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 96.5 m -57.41 166.68 1.54 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.546 -0.721 . . . . 0.0 109.904 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.1 Cg_endo -67.7 115.21 3.63 Favored 'Trans proline' 0 N--CA 1.501 1.947 0 C-N-CA 122.57 2.18 . . . . 0.0 109.256 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.86 12.12 17.07 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.79 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 66.5 p -141.26 161.3 38.2 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.55 142.43 35.17 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.161 -0.962 . . . . 0.0 110.677 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.8 t -82.37 130.7 35.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.421 -0.8 . . . . 0.0 109.391 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.416 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.2 OUTLIER -141.55 128.52 20.69 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.33 163.51 27.86 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.475 -0.766 . . . . 0.0 109.305 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.9 -178.39 4.6 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 121.522 -0.736 . . . . 0.0 109.658 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.96 -32.11 66.97 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.69 -18.7 33.29 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.509 -0.744 . . . . 0.0 110.598 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.72 -20.25 39.57 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.27 150.97 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -1.089 . . . . 0.0 109.42 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 24.2 m -109.73 142.53 40.8 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 120.21 -0.596 . . . . 0.0 109.959 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 73.4 m-85 -135.58 156.55 48.69 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.6 m -83.56 158.28 22.01 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.416 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.4 122.84 7.86 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.3 122.68 11.65 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.577 -0.702 . . . . 0.0 110.462 -178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.95 166.85 0.91 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.637 -0.664 . . . . 0.0 110.033 -179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.59 158.92 42.14 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.507 -0.746 . . . . 0.0 109.508 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.497 1.679 0 C-N-CA 123.488 2.792 . . . . 0.0 110.482 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 tt -94.06 152.32 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.645 -0.66 . . . . 0.0 109.315 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -119.2 176.24 5.41 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.623 -0.673 . . . . 0.0 109.613 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -85.16 -71.09 0.54 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.633 -0.667 . . . . 0.0 109.341 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.64 141.14 4.69 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.926 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.2 166.82 0.15 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.544 -0.974 . . . . 0.0 110.251 179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 49.74 25.07 1.39 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.806 -0.559 . . . . 0.0 111.187 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.474 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.61 158.89 74.55 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.3 Cg_endo -76.44 126.12 8.83 Favored 'Trans proline' 0 N--CA 1.502 2.009 0 C-N-CA 122.951 2.434 . . . . 0.0 111.12 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 98.9 m -55.06 172.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.46 160.92 33.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.521 -0.737 . . . . 0.0 109.525 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.22 -65.74 0.5 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.505 -0.747 . . . . 0.0 110.317 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 12.4 p -51.24 -48.49 62.1 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.492 -0.755 . . . . 0.0 110.477 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.0 m -120.19 138.7 27.44 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 -130.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.25 170.17 9.56 Favored 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 122.894 2.396 . . . . 0.0 109.897 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 58.0 m -73.54 158.6 34.56 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.4 m -56.52 167.71 0.93 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.517 -0.739 . . . . 0.0 109.452 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.11 125.85 13.61 Favored 'Trans proline' 0 N--CA 1.502 2.003 0 C-N-CA 122.618 2.212 . . . . 0.0 109.502 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.99 -36.47 4.33 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 107.612 -2.195 . . . . 0.0 107.612 -177.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.926 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 41.2 p -99.26 158.1 15.93 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -136.64 154.55 50.62 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.188 -0.945 . . . . 0.0 110.8 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.8 t -87.53 131.86 34.23 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.33 -0.856 . . . . 0.0 109.107 179.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.414 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.81 123.21 14.9 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.9 164.69 26.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.517 -0.739 . . . . 0.0 109.61 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -127.62 179.47 5.5 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.584 -0.698 . . . . 0.0 109.245 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.73 -34.49 71.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.821 -0.549 . . . . 0.0 109.594 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.1 p-10 -57.37 -20.4 29.09 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.468 -0.77 . . . . 0.0 110.697 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.35 -18.41 35.8 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.2 t -99.3 148.23 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.312 -1.111 . . . . 0.0 109.403 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.2 m -111.94 144.92 40.49 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 120.183 -0.607 . . . . 0.0 110.161 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 77.4 m-85 -136.83 158.26 44.86 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 81.5 m -85.13 158.0 20.52 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.414 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.01 125.15 9.32 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.442 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.1 OUTLIER -54.84 94.29 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.528 -0.732 . . . . 0.0 110.883 -178.23 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -164.7 170.8 15.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.2 mp0 -88.69 161.23 42.45 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.554 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.736 0 C-N-CA 123.465 2.777 . . . . 0.0 110.481 179.991 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.2 150.2 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.595 -0.69 . . . . 0.0 109.351 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.0 p -121.66 179.02 4.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.598 -0.688 . . . . 0.0 109.74 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.7 m -81.38 -76.08 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 8' ' ' ARG . . . 141.41 139.58 3.69 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.982 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.79 164.8 0.33 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.542 -0.976 . . . . 0.0 110.397 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 49.59 25.62 1.49 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.756 -0.59 . . . . 0.0 111.22 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 5' ' ' GLY . 0.1 OUTLIER -130.79 160.66 65.48 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.355 -0.841 . . . . 0.0 108.758 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -75.83 126.18 9.26 Favored 'Trans proline' 0 N--CA 1.502 1.977 0 C-N-CA 122.969 2.446 . . . . 0.0 110.991 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 80.9 m -52.91 169.38 0.1 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.456 -0.778 . . . . 0.0 109.926 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.85 157.03 42.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.762 . . . . 0.0 109.832 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -66.3 0.41 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.568 -0.707 . . . . 0.0 110.437 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.3 p -50.94 -44.29 60.37 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.429 -0.794 . . . . 0.0 110.525 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 91.1 m -124.53 135.15 26.21 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.215 -0.928 . . . . 0.0 109.262 -134.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -84.93 170.6 9.79 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.835 2.356 . . . . 0.0 110.328 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.15 159.4 34.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.627 -0.671 . . . . 0.0 109.216 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.531 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 89.5 m -56.72 166.87 1.17 Allowed Pre-proline 0 N--CA 1.494 1.772 0 O-C-N 121.492 -0.755 . . . . 0.0 109.745 179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.531 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.54 111.38 2.75 Favored 'Trans proline' 0 N--CA 1.503 2.034 0 C-N-CA 122.62 2.213 . . . . 0.0 109.622 179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.41 -38.75 2.21 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -178.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.982 HG21 ' HB2' ' A' ' 6' ' ' ALA . 70.1 p -98.95 153.68 18.64 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 178.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.01 159.68 35.97 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.421 -0.8 . . . . 0.0 110.364 -179.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.8 t -89.78 130.67 36.0 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.36 124.22 16.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.993 -0.442 . . . . 0.0 109.834 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.67 165.81 9.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.292 179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.92 179.77 5.79 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-O 121.583 0.706 . . . . 0.0 109.734 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.67 -34.88 70.08 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.6 p30 -58.22 -19.37 33.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.56 -0.713 . . . . 0.0 110.594 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.94 -19.8 34.71 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.242 -1.143 . . . . 0.0 110.242 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 31' ' ' TYR . 28.7 t -99.36 149.01 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.32 -1.106 . . . . 0.0 109.426 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.9 m -104.21 142.22 34.91 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.94 -179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 69.2 m-85 -136.28 157.42 46.85 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 77.2 m -84.89 151.88 23.96 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.01 135.64 17.15 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' CD ' HG22 ' A' ' 20' ' ' THR . 1.2 mmmp? -55.54 150.29 12.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.274 -0.891 . . . . 0.0 110.271 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.47 164.05 3.68 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.737 -0.602 . . . . 0.0 109.924 -179.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -71.38 163.05 69.2 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.628 -0.67 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.688 0 C-N-CA 123.442 2.761 . . . . 0.0 110.495 179.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.9 tt -100.75 151.05 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.582 -0.699 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 18.9 p -120.17 172.75 7.55 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.622 -0.674 . . . . 0.0 109.632 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' HB3' ' A' ' 8' ' ' ARG . 84.7 m -80.6 -73.1 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.602 -0.686 . . . . 0.0 109.49 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.0 144.63 5.14 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.054 -1.218 . . . . 0.0 110.054 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.908 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.24 165.97 0.2 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.567 -0.961 . . . . 0.0 110.445 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 48.95 25.56 1.1 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.851 -0.53 . . . . 0.0 111.404 179.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.5 159.01 72.82 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.291 -0.88 . . . . 0.0 108.816 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.6 Cg_endo -76.32 126.03 8.84 Favored 'Trans proline' 0 N--CA 1.501 1.96 0 C-N-CA 122.936 2.424 . . . . 0.0 110.979 -179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.6 m -53.94 172.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.532 -0.73 . . . . 0.0 109.842 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.79 158.64 42.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.513 -0.742 . . . . 0.0 109.618 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -65.86 0.48 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.549 -0.719 . . . . 0.0 110.381 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.6 p -50.99 -45.87 61.19 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.446 -0.784 . . . . 0.0 110.537 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 97.7 m -123.24 136.37 26.97 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.377 -133.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.3 170.15 9.52 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.847 2.365 . . . . 0.0 109.949 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 57.4 m -71.45 157.72 37.55 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.558 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.0 m -56.79 167.97 0.92 Allowed Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.532 -0.73 . . . . 0.0 109.491 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.4 Cg_endo -68.21 127.21 15.49 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 122.571 2.181 . . . . 0.0 109.305 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 108.39 -37.07 3.99 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.344 -2.302 . . . . 0.0 107.344 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.908 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.4 p -99.13 160.2 14.44 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 178.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.56 158.88 43.42 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.295 -0.878 . . . . 0.0 110.38 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.4 t -92.26 131.5 37.42 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.796 . . . . 0.0 109.415 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.66 124.07 15.75 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.81 163.55 23.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.787 . . . . 0.0 109.34 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.78 178.89 6.03 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.526 -0.734 . . . . 0.0 109.303 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.63 -31.53 66.96 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -58.07 -19.49 32.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.56 -0.713 . . . . 0.0 110.576 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.84 -23.84 24.88 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.4 t -99.64 152.22 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 109.503 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.3 m -108.25 146.59 32.63 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.936 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.8 m-85 -135.51 160.59 37.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 76.2 m -89.78 153.48 20.64 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.2 OUTLIER -147.76 126.77 12.82 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 106.644 -1.614 . . . . 0.0 106.644 179.157 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' HD2' HG22 ' A' ' 20' ' ' THR . 22.2 tptm -54.7 94.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.472 -0.767 . . . . 0.0 110.744 -178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -164.45 166.25 20.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -133.54 91.0 27.36 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 0.0 109.637 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.496 1.646 0 C-N-CA 123.369 2.713 . . . . 0.0 110.542 179.959 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.1 tt -71.88 160.29 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.637 -0.664 . . . . 0.0 109.336 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.9 p -117.21 174.3 6.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.564 -0.71 . . . . 0.0 109.615 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.8 m -79.41 -70.71 0.49 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.6 -0.688 . . . . 0.0 109.657 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 131.39 142.19 4.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.91 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.24 164.04 0.34 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.563 -0.963 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 51.28 24.13 1.95 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.85 -0.531 . . . . 0.0 111.258 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -128.98 158.99 70.96 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.359 -0.838 . . . . 0.0 108.825 179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.61 126.23 8.79 Favored 'Trans proline' 0 N--CA 1.501 1.967 0 C-N-CA 123.037 2.491 . . . . 0.0 111.191 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 84.8 m -55.11 171.74 0.14 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.495 -0.753 . . . . 0.0 109.719 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -138.4 159.12 42.88 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.49 -0.756 . . . . 0.0 109.807 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.85 -64.89 0.67 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.491 -0.755 . . . . 0.0 110.565 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.1 p -50.97 -44.96 60.72 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.452 -0.78 . . . . 0.0 110.631 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 79.2 m -124.71 130.22 24.34 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.191 -0.943 . . . . 0.0 109.203 -135.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.0 170.35 9.82 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 122.845 2.364 . . . . 0.0 110.238 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.9 m -70.53 156.88 38.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.555 -0.716 . . . . 0.0 109.201 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 90.2 m -56.53 167.17 1.04 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.542 -0.724 . . . . 0.0 109.618 179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.1 Cg_endo -69.74 112.67 3.14 Favored 'Trans proline' 0 N--CA 1.503 2.063 0 C-N-CA 122.64 2.227 . . . . 0.0 109.536 179.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.62 -37.34 2.63 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 107.493 -2.243 . . . . 0.0 107.493 -178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.91 HG21 ' HB2' ' A' ' 6' ' ' ALA . 79.6 p -98.75 154.45 17.98 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.47 154.08 48.13 Favored 'General case' 0 N--CA 1.502 2.132 0 C-N-CA 119.716 -0.794 . . . . 0.0 110.477 -179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.3 t -87.18 131.78 34.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.172 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.32 124.58 16.5 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.83 166.68 18.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.517 -0.739 . . . . 0.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -127.25 177.44 6.69 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.527 0.68 . . . . 0.0 109.255 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -38.23 75.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.79 -0.569 . . . . 0.0 109.769 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.4 p-10 -57.6 -20.06 30.17 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.471 -0.768 . . . . 0.0 110.739 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.46 -15.6 32.32 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.672 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG11 ' OH ' ' A' ' 31' ' ' TYR . 27.4 t -99.2 146.59 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.2 -1.176 . . . . 0.0 109.434 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.7 m -110.7 144.24 39.94 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 120.257 -0.577 . . . . 0.0 110.221 -179.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.457 ' OH ' HG11 ' A' ' 29' ' ' VAL . 64.1 m-85 -138.03 158.38 44.45 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -84.22 153.77 23.42 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.401 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.26 131.94 14.0 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.164 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -55.39 148.87 14.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 0.0 110.281 -178.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.67 167.69 1.42 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.75 -0.594 . . . . 0.0 109.823 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -138.37 88.43 14.78 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.607 -0.683 . . . . 0.0 109.564 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.398 2.732 . . . . 0.0 110.484 179.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 3.7 tt -63.59 153.47 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 20.1 p -116.98 172.07 7.5 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.6 -0.688 . . . . 0.0 109.749 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.3 m -80.71 -73.73 0.35 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 135.05 141.06 4.33 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.907 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.97 164.24 0.41 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.552 -0.969 . . . . 0.0 110.083 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 53.99 23.3 3.9 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.788 -0.57 . . . . 0.0 110.835 179.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.487 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.09 159.39 72.33 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 179.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 124.68 8.14 Favored 'Trans proline' 0 N--CA 1.501 1.925 0 C-N-CA 122.928 2.418 . . . . 0.0 110.93 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -55.53 172.18 0.17 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.515 -0.74 . . . . 0.0 109.714 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -133.75 158.57 42.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.588 -0.695 . . . . 0.0 109.809 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.97 -65.19 0.6 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.558 -0.714 . . . . 0.0 110.424 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.5 p -50.92 -44.83 60.27 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.445 -0.784 . . . . 0.0 110.589 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 87.3 m -124.31 134.19 25.3 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.109 -0.994 . . . . 0.0 109.341 -134.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -85.1 170.49 9.63 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.823 2.348 . . . . 0.0 110.101 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 61.9 m -72.19 158.68 35.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.666 -0.646 . . . . 0.0 109.352 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 94.2 m -57.09 166.57 1.41 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.596 -0.69 . . . . 0.0 109.635 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -69.31 123.97 10.79 Favored 'Trans proline' 0 N--CA 1.502 2.001 0 C-N-CA 122.651 2.234 . . . . 0.0 109.39 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.17 -36.12 4.39 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 -177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.907 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 32.5 p -98.42 156.81 16.57 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.78 140.76 42.76 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.268 -0.895 . . . . 0.0 110.963 -179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.5 t -65.55 143.11 57.84 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.405 ' CE ' ' CB ' ' A' ' 33' ' ' ARG . 24.7 mttm -140.75 177.19 8.2 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.92 154.09 44.94 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 0.0 109.211 179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.42 177.55 5.57 Favored 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 121.727 0.775 . . . . 0.0 109.758 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.33 -32.59 66.65 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -58.78 -18.67 33.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.581 -0.699 . . . . 0.0 110.536 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.21 -12.64 55.35 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 23.9 t -99.26 147.91 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.21 -1.171 . . . . 0.0 109.284 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.2 m -105.64 144.19 32.74 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.232 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.1 m-85 -140.69 148.89 41.49 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 60.8 m -71.28 163.12 28.27 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.405 ' CB ' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -149.96 118.58 6.54 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.343 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.13 141.67 53.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.658 -0.651 . . . . 0.0 109.973 -178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -58.27 172.78 0.42 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.765 -0.584 . . . . 0.0 110.036 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -109.96 109.78 59.07 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.608 -0.683 . . . . 0.0 109.465 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.498 1.783 0 C-N-CA 123.08 2.52 . . . . 0.0 110.495 179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 11.5 tt -63.93 151.62 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.608 -0.682 . . . . 0.0 109.344 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -120.5 175.96 5.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.654 -0.654 . . . . 0.0 109.615 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 8' ' ' ARG . 89.9 m -81.28 -71.45 0.47 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.635 -0.666 . . . . 0.0 109.542 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.51 142.05 4.79 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.011 -1.236 . . . . 0.0 110.011 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.883 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.11 166.73 0.15 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.551 -0.97 . . . . 0.0 110.386 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 50.58 24.02 1.51 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.883 -0.511 . . . . 0.0 111.346 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.3 159.69 69.31 Favored Pre-proline 0 N--CA 1.496 1.873 0 O-C-N 121.24 -0.912 . . . . 0.0 108.875 179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.9 Cg_endo -76.02 125.94 8.98 Favored 'Trans proline' 0 N--CA 1.503 2.041 0 C-N-CA 123.02 2.48 . . . . 0.0 111.092 -179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 70.8 m -54.55 170.68 0.15 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.519 -0.738 . . . . 0.0 109.76 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.37 157.27 47.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.52 -0.738 . . . . 0.0 109.853 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.15 -65.35 0.57 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.485 -0.759 . . . . 0.0 110.464 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.2 p -50.74 -43.82 58.24 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.469 -0.769 . . . . 0.0 110.586 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 74.5 m -125.71 131.09 23.92 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 109.2 -136.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -84.76 170.0 10.29 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.782 2.322 . . . . 0.0 110.087 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 47.0 m -70.88 159.12 35.23 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 97.5 m -56.75 167.11 1.11 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.505 -0.747 . . . . 0.0 109.666 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.92 114.37 3.71 Favored 'Trans proline' 0 N--CA 1.503 2.03 0 C-N-CA 122.664 2.243 . . . . 0.0 109.468 179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 122.72 -36.05 3.24 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 107.616 -2.194 . . . . 0.0 107.616 -178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.883 HG21 ' HB2' ' A' ' 6' ' ' ALA . 72.2 p -98.51 153.96 18.24 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.41 154.81 46.57 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 -179.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.6 t -91.62 129.55 37.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.375 -0.828 . . . . 0.0 109.283 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' HE3' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.28 130.05 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -72.43 163.88 27.28 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.745 . . . . 0.0 109.396 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.97 -179.51 5.14 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 121.558 -0.714 . . . . 0.0 109.277 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.19 -31.7 67.96 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -57.75 -19.95 31.37 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.513 -0.742 . . . . 0.0 110.622 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.72 -22.07 30.96 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.3 t -99.49 152.23 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -1.065 . . . . 0.0 109.587 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.1 m -108.82 144.6 36.47 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 120.219 -0.592 . . . . 0.0 109.681 -179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.3 m-85 -135.94 159.92 40.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.633 -0.667 . . . . 0.0 109.242 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 69.4 m -86.04 151.65 23.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -150.82 130.76 13.34 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.68 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -53.83 149.06 9.19 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.321 -0.862 . . . . 0.0 110.215 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -60.27 157.38 13.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.724 -0.61 . . . . 0.0 109.858 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 26.6 mm-40 -138.77 81.97 21.9 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.571 -0.705 . . . . 0.0 109.417 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.496 1.663 0 C-N-CA 123.487 2.791 . . . . 0.0 110.481 -179.937 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -70.14 147.25 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.529 -0.732 . . . . 0.0 109.36 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 16.8 p -122.17 174.45 6.95 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.712 -0.618 . . . . 0.0 109.516 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 8' ' ' ARG . 93.0 m -80.35 -75.31 0.27 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.633 -0.667 . . . . 0.0 109.432 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 137.15 143.23 4.54 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.887 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.22 166.24 0.18 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.563 -0.963 . . . . 0.0 110.406 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.98 25.48 1.09 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.865 -0.522 . . . . 0.0 111.37 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.441 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -130.87 160.22 67.64 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.298 -0.876 . . . . 0.0 108.847 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.412 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.09 126.96 9.62 Favored 'Trans proline' 0 N--CA 1.502 2.016 0 C-N-CA 122.947 2.431 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 73.1 m -53.87 170.79 0.11 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.48 -0.762 . . . . 0.0 109.81 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -131.52 157.32 43.88 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.491 -0.756 . . . . 0.0 109.813 -179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.8 -66.4 0.39 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.517 -0.74 . . . . 0.0 110.496 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.0 p -50.86 -44.48 59.54 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.41 -0.806 . . . . 0.0 110.554 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 93.5 m -124.49 136.21 27.52 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.954 . . . . 0.0 109.361 -134.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -85.02 170.2 9.86 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.797 2.332 . . . . 0.0 110.001 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 56.3 m -70.48 158.61 35.76 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 86.4 m -56.78 167.63 1.0 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.551 -0.718 . . . . 0.0 109.589 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.5 Cg_endo -68.7 121.55 8.45 Favored 'Trans proline' 0 N--CA 1.502 2.024 0 C-N-CA 122.682 2.255 . . . . 0.0 109.458 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 114.33 -37.98 3.34 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 107.377 -2.289 . . . . 0.0 107.377 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.887 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 42.1 p -99.19 156.24 17.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.1 161.01 36.03 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.358 -0.839 . . . . 0.0 110.397 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 22.0 t -92.24 131.07 37.75 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.45 -0.781 . . . . 0.0 109.293 179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.73 124.74 16.23 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.54 165.86 16.01 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.479 -0.763 . . . . 0.0 109.307 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -131.96 -179.23 5.28 Favored 'General case' 0 N--CA 1.483 1.177 0 O-C-N 121.565 -0.709 . . . . 0.0 109.704 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.8 -32.53 67.71 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -58.92 -18.48 33.87 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.521 -0.737 . . . . 0.0 110.64 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.76 -21.74 33.59 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 29.5 t -99.47 151.89 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.427 -1.043 . . . . 0.0 109.346 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 m -107.34 144.76 33.73 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.947 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.412 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 92.0 m-85 -135.58 159.6 41.09 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.8 m -88.97 153.0 21.38 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -146.98 126.04 12.87 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 179.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.53 ' HA ' HG22 ' A' ' 20' ' ' THR . 0.0 OUTLIER -54.91 96.87 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.822 . . . . 0.0 110.332 -178.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.89 179.31 7.87 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 121.812 -0.555 . . . . 0.0 109.676 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -138.4 75.6 38.73 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.586 -0.696 . . . . 0.0 109.288 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.496 1.651 0 C-N-CA 123.476 2.784 . . . . 0.0 110.532 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.8 mt -63.41 136.93 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.564 -0.71 . . . . 0.0 109.333 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.403 ' HB2' ' N ' ' A' ' 17' ' ' CYS . 15.8 p -125.96 -178.43 4.29 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.629 -0.669 . . . . 0.0 109.841 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 8' ' ' ARG . 69.8 m -90.36 -68.83 0.76 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.19 142.0 4.82 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.931 ' HB2' HG21 ' A' ' 20' ' ' THR . . . -52.3 163.9 0.36 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.53 -0.983 . . . . 0.0 110.531 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 51.11 24.88 2.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.796 -0.565 . . . . 0.0 111.209 179.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -130.55 159.14 72.28 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.355 -0.84 . . . . 0.0 108.749 179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.2 Cg_endo -76.25 126.67 9.32 Favored 'Trans proline' 0 N--CA 1.503 2.077 0 C-N-CA 123.017 2.478 . . . . 0.0 111.163 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 71.2 m -54.96 171.39 0.14 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.466 -0.771 . . . . 0.0 109.744 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -141.5 158.29 44.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.456 -0.778 . . . . 0.0 110.043 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.24 -66.33 0.4 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.577 -0.702 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.5 p -50.63 -41.97 55.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.495 -0.753 . . . . 0.0 110.534 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -127.09 121.93 22.96 Favored Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.202 -0.937 . . . . 0.0 109.012 -137.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -83.74 169.94 11.7 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 122.754 2.303 . . . . 0.0 110.286 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.3 m -66.96 153.3 43.94 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.534 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 73.9 m -57.0 166.88 1.24 Allowed Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.629 -0.67 . . . . 0.0 109.801 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.534 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.9 Cg_endo -69.1 111.79 2.78 Favored 'Trans proline' 0 N--CA 1.503 2.057 0 C-N-CA 122.594 2.196 . . . . 0.0 109.572 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.43 -39.12 2.06 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.931 HG21 ' HB2' ' A' ' 6' ' ' ALA . 69.4 p -98.44 155.07 17.43 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -132.81 150.87 52.11 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.35 -0.844 . . . . 0.0 110.728 -179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 17.1 t -82.09 131.99 35.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.531 -0.731 . . . . 0.0 109.152 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.51 124.55 16.29 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.95 164.2 24.38 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.488 -0.758 . . . . 0.0 109.283 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -128.4 178.12 6.5 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.538 -0.726 . . . . 0.0 109.332 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.14 -33.85 70.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.793 -0.567 . . . . 0.0 109.478 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -57.79 -19.86 31.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.554 -0.716 . . . . 0.0 110.608 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.2 -20.09 31.2 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.35 150.28 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.316 -1.108 . . . . 0.0 109.582 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 17.0 m -109.87 142.84 40.62 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 120.22 -0.592 . . . . 0.0 110.025 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 78.6 m-85 -136.27 157.97 45.53 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 85.3 m -84.41 154.65 22.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.23 130.64 12.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 9.7 tptt -56.64 145.12 29.61 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.359 -0.838 . . . . 0.0 110.028 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -60.56 171.12 1.19 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.747 -0.596 . . . . 0.0 109.903 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -154.09 84.31 4.08 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.656 -0.653 . . . . 0.0 109.433 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.497 1.694 0 C-N-CA 123.428 2.752 . . . . 0.0 110.488 -179.932 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.7 mt -74.95 138.82 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.578 -0.702 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 19.1 p -115.82 -179.82 3.76 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.597 -0.69 . . . . 0.0 109.63 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.56 HG22 ' HB3' ' A' ' 8' ' ' ARG . 62.9 m -91.52 -70.7 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.632 -0.668 . . . . 0.0 109.294 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 132.77 143.56 5.08 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.906 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -51.95 166.6 0.14 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.454 -1.027 . . . . 0.0 110.326 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 49.85 24.84 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.83 -0.543 . . . . 0.0 111.379 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.56 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -131.89 159.91 69.98 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.252 -0.905 . . . . 0.0 108.998 179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.5 Cg_endo -76.57 129.24 10.81 Favored 'Trans proline' 0 N--CA 1.503 2.059 0 C-N-CA 123.067 2.512 . . . . 0.0 111.295 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.23 174.14 0.42 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.514 -0.741 . . . . 0.0 109.369 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -148.52 160.57 42.95 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.27 -67.62 0.24 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.552 -0.717 . . . . 0.0 110.617 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -50.58 -41.12 54.02 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.475 -0.766 . . . . 0.0 110.511 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 76.3 m -126.98 111.71 21.88 Favored Pre-proline 0 C--N 1.302 -1.496 0 O-C-N 121.266 -0.896 . . . . 0.0 109.045 -137.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.28 169.64 15.61 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 122.588 2.192 . . . . 0.0 110.371 -179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 35.5 m -65.59 150.33 48.6 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.533 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 75.9 m -56.96 167.27 1.12 Allowed Pre-proline 0 N--CA 1.494 1.725 0 O-C-N 121.637 -0.664 . . . . 0.0 109.716 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.7 Cg_endo -68.96 115.48 4.0 Favored 'Trans proline' 0 N--CA 1.502 2.006 0 C-N-CA 122.597 2.198 . . . . 0.0 109.393 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 123.21 -38.59 2.44 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.293 -2.323 . . . . 0.0 107.293 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.906 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 67.9 p -98.06 155.37 17.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.28 153.37 47.87 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.564 -0.854 . . . . 0.0 110.867 -178.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 20.0 t -88.66 134.05 34.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.481 -0.762 . . . . 0.0 109.221 179.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -141.1 179.71 6.59 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -117.4 160.0 21.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.43 -0.794 . . . . 0.0 109.329 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.91 177.62 5.67 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 121.517 -0.739 . . . . 0.0 109.288 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.05 -34.67 71.47 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -57.44 -20.31 29.57 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.54 -0.725 . . . . 0.0 110.599 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.0 -14.91 44.52 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 t -99.19 148.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.23 -1.159 . . . . 0.0 109.512 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.9 m -100.74 145.67 28.2 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.279 0.561 . . . . 0.0 109.895 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 86.8 m-85 -140.19 158.33 44.21 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 74.9 m -86.21 156.37 20.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.411 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 127.59 10.72 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.071 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 20' ' ' THR . 3.0 ttpt -55.89 147.01 20.34 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.459 -0.775 . . . . 0.0 110.256 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -64.19 -177.08 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.197 0.522 . . . . 0.0 109.832 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -145.0 162.48 37.75 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.596 -0.69 . . . . 0.0 109.344 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo . . . . . 0 N--CA 1.497 1.696 0 C-N-CA 123.441 2.761 . . . . 0.0 110.503 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 13.2 tt -91.63 153.96 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.606 -0.683 . . . . 0.0 109.588 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 17.4 p -118.21 171.84 7.84 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.562 -0.711 . . . . 0.0 109.511 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.467 HG22 ' HB3' ' A' ' 8' ' ' ARG . 87.1 m -80.72 -71.74 0.45 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.578 -0.701 . . . . 0.0 109.355 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 133.19 141.34 4.56 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.902 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.06 167.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.594 -0.945 . . . . 0.0 110.267 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 50.68 24.34 1.66 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.813 -0.554 . . . . 0.0 111.077 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.467 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.0 OUTLIER -132.79 158.64 75.25 Favored Pre-proline 0 N--CA 1.496 1.843 0 O-C-N 121.286 -0.884 . . . . 0.0 108.702 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 39.5 Cg_endo -75.73 125.58 8.94 Favored 'Trans proline' 0 N--CA 1.501 1.966 0 C-N-CA 122.962 2.441 . . . . 0.0 111.132 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 86.9 m -54.66 172.85 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.515 -0.741 . . . . 0.0 109.788 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.06 159.37 41.74 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.512 -0.743 . . . . 0.0 109.878 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.7 -66.35 0.4 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.549 -0.719 . . . . 0.0 110.398 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.8 p -51.0 -45.06 61.07 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.45 -0.781 . . . . 0.0 110.525 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 86.0 m -124.44 133.92 25.12 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.207 -0.933 . . . . 0.0 109.358 -134.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -85.36 170.62 9.24 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.839 2.36 . . . . 0.0 110.1 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.7 m -72.09 158.67 35.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.622 -0.674 . . . . 0.0 109.21 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 99.0 m -57.01 167.73 1.03 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.552 -0.717 . . . . 0.0 109.5 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 36.3 Cg_endo -68.41 131.09 22.39 Favored 'Trans proline' 0 N--CA 1.502 2.029 0 C-N-CA 122.512 2.142 . . . . 0.0 109.224 179.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 104.55 -34.96 5.38 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 107.577 -2.209 . . . . 0.0 107.577 -177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.902 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 37.9 p -99.02 158.01 15.95 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -133.49 159.01 41.65 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.241 -0.912 . . . . 0.0 110.564 -179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 23.3 t -98.22 129.26 44.97 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.291 -0.881 . . . . 0.0 109.378 179.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -142.07 128.06 19.55 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.854 -0.529 . . . . 0.0 109.647 -179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.18 165.87 17.4 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.536 -0.728 . . . . 0.0 109.485 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.85 179.42 5.86 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.6 -0.687 . . . . 0.0 109.321 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.23 -32.88 69.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.736 -0.603 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -58.46 -19.01 33.12 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.533 -0.729 . . . . 0.0 110.66 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.29 -22.59 28.8 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.0 t -99.52 150.18 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.395 -1.062 . . . . 0.0 109.421 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.2 m -105.76 147.27 28.79 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 120.145 -0.622 . . . . 0.0 109.862 -179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 80.2 m-85 -136.15 161.34 35.99 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 63.0 m -89.02 158.78 17.89 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.11 121.55 7.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HG3' HG22 ' A' ' 20' ' ' THR . 12.2 tttt -55.55 93.59 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.606 -0.684 . . . . 0.0 110.685 -178.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -164.37 166.07 21.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -89.98 159.78 42.04 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.57 -0.706 . . . . 0.0 109.535 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo . . . . . 0 N--CA 1.496 1.672 0 C-N-CA 123.435 2.756 . . . . 0.0 110.53 179.945 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -72.74 149.09 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.569 -0.707 . . . . 0.0 109.356 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.4 p -122.84 175.12 6.72 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.636 -0.665 . . . . 0.0 109.562 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 8' ' ' ARG . 91.5 m -83.39 -69.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 129.3 143.1 5.44 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.916 ' HB2' ' CG2' ' A' ' 20' ' ' THR . . . -52.15 167.18 0.13 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.625 -0.927 . . . . 0.0 110.114 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 51.06 24.02 1.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.822 -0.548 . . . . 0.0 111.093 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' HB3' HG22 ' A' ' 4' ' ' THR . 0.1 OUTLIER -132.21 158.34 75.84 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.278 -0.889 . . . . 0.0 108.658 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . 40.0 Cg_endo -76.39 124.61 7.86 Favored 'Trans proline' 0 N--CA 1.502 1.975 0 C-N-CA 122.931 2.421 . . . . 0.0 111.149 -179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 97.3 m -54.52 172.37 0.1 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.53 -0.731 . . . . 0.0 109.779 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -135.72 159.89 40.22 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.509 -0.744 . . . . 0.0 109.903 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.58 -66.54 0.37 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.549 -0.719 . . . . 0.0 110.494 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.9 p -50.91 -44.85 60.12 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.448 -0.782 . . . . 0.0 110.553 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.9 m -124.58 132.24 24.27 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 -134.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.98 170.01 9.99 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 C-N-CA 122.815 2.343 . . . . 0.0 109.998 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.7 m -70.21 160.52 31.99 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 18' ' ' PRO . 93.0 m -56.95 166.9 1.22 Allowed Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.552 -0.717 . . . . 0.0 109.73 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 17' ' ' CYS . 37.0 Cg_endo -69.57 116.97 4.79 Favored 'Trans proline' 0 N--CA 1.502 1.996 0 C-N-CA 122.702 2.268 . . . . 0.0 109.506 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.66 -36.08 3.61 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 107.719 -2.153 . . . . 0.0 107.719 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.916 ' CG2' ' HB2' ' A' ' 6' ' ' ALA . 68.5 p -97.66 156.66 16.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.1 158.08 39.95 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.293 -0.88 . . . . 0.0 110.873 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.4 t -98.48 130.57 45.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.354 -0.841 . . . . 0.0 109.411 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.42 ' CE ' ' HB2' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -141.69 129.43 21.64 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -75.48 164.76 26.03 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.465 -0.772 . . . . 0.0 109.703 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -127.59 -177.6 4.15 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.655 -0.653 . . . . 0.0 109.317 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.15 -32.93 69.55 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.761 -0.587 . . . . 0.0 109.487 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 26.1 p30 -58.26 -19.19 32.28 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.513 -0.742 . . . . 0.0 110.715 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 -19.96 39.31 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 36.9 t -99.37 149.2 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.37 -1.076 . . . . 0.0 109.369 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.6 m -110.51 147.14 34.75 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.889 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CE2' ' HB3' ' A' ' 9' ' ' PRO . 64.5 m-85 -135.88 161.17 36.37 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 61.9 m -87.47 159.02 18.82 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.42 ' HB2' ' CE ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -151.55 124.68 8.71 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 179.084 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.452 ' HA ' HG22 ' A' ' 20' ' ' THR . 21.0 pttt -56.58 145.79 27.2 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.559 -0.713 . . . . 0.0 110.48 -178.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -79.89 -172.96 3.63 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -131.76 153.22 81.4 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.74 . . . . 0.0 109.462 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 N--CA 1.498 1.755 0 C-N-CA 123.29 2.66 . . . . 0.0 110.453 179.97 . . . . . . . . 0 0 . 1 stop_ save_